In Segment A, individuals will get various doses and schedules of oral ABBV-744 tablet to detect Protected dosing routine. Additional individuals might be enrolled in the determined monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be given as "include-on" therapy. In Section C, members https://phils998eqa1.thelateblog.com/profile